Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Systematic Review on Overall Survival and Disease-Free Survival Following Total Pelvic Exenteration Publisher Pubmed



Miri SR1 ; Akhavan S2 ; Mousavi AS2 ; Hashemi SR3 ; Sheikhhasani S3 ; Almasihashiani A4, 5 ; Fakhari MS6 ; Esmailzadeh A2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Gynecology Oncology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Obstetrics and Gynecology, Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
  4. 4. Department of Epidemiology, Arak University of Medical Sciences, Arak, Iran
  5. 5. Traditional and Complementary Medicine Research Center, Arak University of Medical Sciences, Arak, Iran
  6. 6. Student Research Committee, Arak University of Medical Sciences, Arak, Iran

Source: Asian Pacific Journal of Cancer Prevention Published:2022


Abstract

Backgrounds: Total Pelvic Exenteration (TPE) is a radical operation for malignancies in which all of the organs inside the pelvic cavity, including the female reproductive organs, the lower urinary tract, and a part of the rectosigmoid are removed. In this study, we aimed to conduct a systematic review to assess the overall survival (OS) and disease-free survival (DFS) following TPE. Methods: This systematic review is composed of a comprehensive review of PubMed and Scopus databases with various related keywords to synthesis the overall survival and disease-free survival following TPE. The Synthesis Without Meta-analysis guideline was used to summarize the results. Results: We included the results of 39 primary studies and the results revealed that one-year OS of gynecological cancer in patients who have undergone TPE ranged from 50.0% to 72.0% and the 5-years OS ranged from 6.0% to 64.6%. The one-year survival rate of colorectal cancer patients was reported to be over 80% in almost all studies. The 3-year survival rate of patients varied from 25% to 75% and the lowest 5-year survival rate was 8% and the highest survival rate was 92%. To synthesis the disease-free survival rate in colorectal cancer, ten studies were included and one-year recurrence rate was 9.1% and the one-year DFS was reported as 61.0%. Three-year recurrence rate study was 20.4% and 3 and 5-year DFS ranged from 22.0% to 78.0%. Conclusions: The results suggested that DFS in primary advanced cancers is higher than locally recurrence tumors. This review showed that patient overall survival and disease-free survival rates have increased over time, especially at high volume centers that are more experienced and possibly better equipped. Therefore, it can be suggested that the attitude towards PE as a palliative surgery can be turned into curative surgery © This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License
Related Docs
1. A Systematic Review and Meta-Analysis on Mortality Rate Following Total Pelvic Exenteration in Cancer Patients, BMC Cancer (2024)
2. Assessment of Synthesized Chitosan/Halloysite Nanocarrier Modified by Carbon Nanotube for Ph-Sensitive Delivery of Curcumin to Cancerous Media, International Journal of Biological Macromolecules (2023)
3. Oncolytic Viruses Against Cancer, Promising or Delusion?, Medical Oncology (2023)
4. Cross-Cultural Adaptation of the Persian Version of “Spiritual Dryness Scale” in Patients With Cancer: From Low Perception of Sacredness of Life to Depressive Symptoms and Emotional Exhaustion, Mental Health# Religion and Culture (2023)
5. The 15-Year National Trends of Genital Cancer Incidence Among Iranian Men and Women; 2005–2020, BMC Public Health (2023)
6. Cerium(Iv) Oxide:Silver/Graphene Oxide (Ceo2:Ag/Go) Nanoparticles Modulate Gene Expression and Inhibit Colorectal Cancer Cell Growth: A Pathway-Centric Therapeutic Approach, Cancer Nanotechnology (2024)
7. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment, Regenerative Engineering and Translational Medicine (2024)
8. The Effect of Harmonization on the Variability of Pet Radiomic Features Extracted Using Various Segmentation Methods, Annals of Nuclear Medicine (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Reza Ay (1)
Mona Navaei-Nigjeh (1)